See more : Pfizer Inc. (PFE.NE) Income Statement Analysis – Financial Results
Complete financial analysis of Forian Inc. (FORA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Forian Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Montego Resources Inc. (MONGF) Income Statement Analysis – Financial Results
- Zotye Automobile Co., Ltd (000980.SZ) Income Statement Analysis – Financial Results
- Sichuan Goldstone Asia Pharmaceutical Inc. (300434.SZ) Income Statement Analysis – Financial Results
- BSE Limited (BSE.NS) Income Statement Analysis – Financial Results
- Napatech A/S (NAPA.OL) Income Statement Analysis – Financial Results
Forian Inc. (FORA)
About Forian Inc.
Forian Inc. provides software solutions, proprietary data driven insights, and predictive analytics to optimize the operational, clinical, and financial performance of its healthcare, cannabis, and government customers. It operates through three segments: Information & Software, Services, and Other. The company's products include BioTrack, a vertically integrated point of sale, manufacturing, delivery, and cultivator software solution for dispensaries, cultivators, manufacturers, and distributors; and Cannalytics, a Software as a Service based analytics solution that provides clients with a presentation of business performance. Its products also comprise BioTrack seed-to-sale compliance traceability platform, which is used to manage the tracking and tracing of various cannabis products from cultivation to sale; BioTrack State Traceability & Enforcement Monitoring System to ensure transparency and accountability throughout cannabis supply chain; and STEMS, a seed-to-sale tracking module, to provide cannabis program management solution to cannabis regulatory agencies. In addition, the company offers security monitoring and web marketing services. The company is headquartered in Newtown, Pennsylvania.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 20.48M | 28.01M | 16.88M | 544.87K | 0.00 |
| Cost of Revenue | 5.48M | 6.87M | 4.72M | 38.29K | 854.00 |
| Gross Profit | 15.00M | 21.13M | 12.16M | 506.58K | -854.00 |
| Gross Profit Ratio | 73.26% | 75.45% | 72.05% | 92.97% | 0.00% |
| Research & Development | 1.41M | 12.35M | 8.98M | 2.51M | 827.47K |
| General & Administrative | 13.63M | 20.53M | 23.46M | 2.98M | 0.00 |
| Selling & Marketing | 4.88M | 5.87M | 4.14M | 573.85K | 0.00 |
| SG&A | 18.52M | 26.40M | 27.61M | 2.98M | 463.84K |
| Other Expenses | 674.27K | 2.89M | 1.99M | 0.00 | 0.00 |
| Operating Expenses | 20.60M | 41.64M | 38.57M | 5.49M | 1.29M |
| Cost & Expenses | 26.08M | 48.51M | 43.29M | 5.53M | 1.29M |
| Interest Income | 2.33M | 267.13K | 6.81K | 3.57K | 5.00K |
| Interest Expense | 834.79K | 873.34K | 322.38K | 0.00 | 0.00 |
| Depreciation & Amortization | 96.33K | 67.18K | 2.21M | 8.56K | 854.00 |
| EBITDA | 2.75M | -18.25M | -24.00M | -4.97M | -1.29M |
| EBITDA Ratio | 13.43% | -61.01% | -143.31% | -913.75% | 0.00% |
| Operating Income | -5.60M | -20.51M | -26.41M | -4.98M | -1.29M |
| Operating Income Ratio | -27.32% | -73.23% | -156.44% | -914.67% | 0.00% |
| Total Other Income/Expenses | 7.41M | -215.20K | 1.09M | 3.57K | 3.33K |
| Income Before Tax | 1.82M | -25.95M | -26.53M | -4.98M | -1.29M |
| Income Before Tax Ratio | 8.88% | -92.65% | -157.16% | -914.01% | 0.00% |
| Income Tax Expense | 85.74K | 23.98K | 22.51K | -3.57K | -4.00 |
| Net Income | 11.11M | -25.97M | -26.55M | -4.98M | -1.29M |
| Net Income Ratio | 54.23% | -92.74% | -157.30% | -913.36% | 0.00% |
| EPS | 0.35 | -0.81 | -0.84 | -0.17 | -0.04 |
| EPS Diluted | 0.34 | -0.81 | -0.84 | -0.17 | -0.04 |
| Weighted Avg Shares Out | 32.03M | 32.03M | 31.77M | 29.82M | 29.82M |
| Weighted Avg Shares Out (Dil) | 32.23M | 32.03M | 31.77M | 29.82M | 29.82M |
VerticalScope to Report First Quarter 2022 Financial Results on May 10, 2022
VerticalScope Announces Record Q1 Monthly Active Users and Provides Acquisitions Update
Forian BioTrack Launches New Mexico Traceability Software for Adult Use Cannabis
VerticalScope Bolsters Senior Leadership Team With Appointment of Paul Lee as Chief Product Officer
Forian Inc's (FORA) CEO Dan Barton on Q4 2021 Results - Earnings Call Transcript
Forian Inc. Announces Fourth Quarter and Full Year 2021 Financial Results
Forian Inc. to Present at 34th Annual Roth Conference
VerticalScope Announces Fourth Quarter and Full Year 2021 Financial Results
VerticalScope Announces Fourth Quarter and Full Year 2021 Financial Results
Forian Inc. to Announce Fourth Quarter and Full Year 2021 Results on March 24, 2022
Source: https://incomestatements.info
Category: Stock Reports